GOCO.NASDAQGohealth, INC
10-Q: GoHealth Reports Q3 2024 Results, Includes Gain on Bargain Purchase from e-TeleQuote Acquisition
Sentiment:
Quarterly Report
GoHealth's Q3 2024 results show a net income of $15.4 million, which includes a significant gain from the acquisition of e-TeleQuote Insurance, Inc.
Capital raiseThe company may need to raise additional funds, which may include the sale of equity securities or through debt financing arrangements.The incurrence of additional debt financing would result in debt service obligations and any future instruments governing such debt could provide for operating and financing covenants that could restrict our operations.
Worse than expectedNet revenues decreased in both the three and nine month periods compared to the prior year periods.Adjusted EBITDA decreased in both the three and nine month periods compared to the prior year periods.
Summary
- GoHealth reported a net income of $15.4 million for the third quarter of 2024, a significant turnaround from a net loss of $56.2 million in the same period last year.
- The company's net revenues were $118.3 million, down from $132 million in Q3 2023.
- This quarter's results include a gain on bargain purchase of $77.4 million related to the acquisition of e-TeleQuote Insurance, Inc.
- Operating expenses totaled $161 million, compared to $170 million in the prior year period.
- The company's adjusted EBITDA was a loss of $12.1 million, compared to a loss of $11.5 million in Q3 2023.
- For the nine months ended September 30, 2024, GoHealth reported a net loss of $65.3 million, compared to a net loss of $149 million in the same period last year.
- The company's net revenues for the nine months ended September 30, 2024 were $409.8 million, down from $458 million in the same period last year.
- The adjusted EBITDA for the nine months ended September 30, 2024 was $2.5 million, compared to $18.1 million in the same period last year.
Sentiment
Score: 5
Explanation: The document presents mixed results. While there's a significant gain from the e-TeleQuote acquisition, the core business shows a decline in revenue and adjusted EBITDA. The company is also facing challenges in the Medicare market and has a high debt load. The sentiment is neutral to slightly negative.
Positives
- The company achieved a net income of $15.4 million in Q3 2024, a significant improvement from the net loss in the same period last year.
- The acquisition of e-TeleQuote Insurance, Inc. resulted in a $77.4 million gain on bargain purchase.
- The company has reduced operating expenses to $161 million in Q3 2024 from $170 million in Q3 2023.
Negatives
- Net revenues decreased to $118.3 million in Q3 2024 from $132 million in Q3 2023.
- The company's adjusted EBITDA was a loss of $12.1 million in Q3 2024, compared to a loss of $11.5 million in Q3 2023.
- The company's net loss for the nine months ended September 30, 2024 was $65.3 million, compared to a net loss of $149 million in the same period last year.
- The company's net revenues for the nine months ended September 30, 2024 were $409.8 million, down from $458 million in the same period last year.
- The adjusted EBITDA for the nine months ended September 30, 2024 was $2.5 million, compared to $18.1 million in the same period last year.
Risks
- The company's operating cash flows could be adversely impacted by a substantial increase in marketing and advertising expenses as a result of a higher volume of Submissions during the fourth quarter.
- The company is actively looking to terminate or sublease certain office spaces and call centers, which could result in future impairments.
- Weakening industry or economic trends, disruptions to the Company's business, changes in discount rate assumptions, unexpected significant changes or planned changes in the use of the assets or in the Companys entity structure are all factors which may adversely impact the assumptions used in the valuation of intangible assets.
- The company's contracts with health plan partners expose it to credit risk because a financial loss could be incurred if the counterparty does not fulfill its financial obligation.
Future Outlook
The company is analyzing the implications of the CMS Final Rule with its health plan partners and closely monitoring its effects on the Medicare landscape, including as it may relate to availability of special enrollment periods for special needs plans.
Management Comments
- GoHealth has evolved from a traditional Medicare enrollment company to a Medicare engagement company, focusing on forging high-quality relationships with our consumers.
- We believe our end-to-end Encompass model offers a differentiated way for Medicare beneficiaries to navigate the complex Medicare Advantage plan selection process and begin to utilize their new plan benefits with greater confidence.
- We continue to refine our Encompass operating model through investments in technology.
- We are analyzing the implications of the CMS Final Rule with our health plan partners and closely monitoring its effects on the Medicare landscape, including as it may relate to availability of special enrollment periods for special needs plans.
- Through the integration of e-TeleQuotes licensed agents into our independent network of external agents, we believe we are well-positioned to leverage this expanded agent base, strengthening our market position and expanding our capacity to deliver high-quality consumer experiences.
Industry Context
The Medicare market is experiencing a shift in dynamics, with health plan partners making fewer changes to benefits, leading to higher shopping but lower switching. The CMS Final Rule has implications for Medicare Advantage plans, potentially affecting benefit structures and necessitating more dynamic consumer shopping behaviors during the upcoming AEP.
Comparison to Industry Standards
- The document does not provide specific comparisons to industry standards.
- However, the document does mention that health plan partners are making very little change to benefits, with many reducing benefits for the average Medicare consumer, which is a trend in the industry.
- The document also mentions that the CMS Final Rule has implications for Medicare Advantage plans, potentially affecting benefit structures and necessitating more dynamic consumer shopping behaviors during the upcoming AEP, which is a broader industry trend.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Executive Officer | Vijay Kotte | na | na | |
| Chief Financial Officer | Brendan Shanahan | na | na |
Legal Proceedings
- In December 2023, the parties notified the court that they had reached an agreement in principle to settle the Securities Class Action.
- On February 7, 2024, the plaintiffs filed an application with the court seeking preliminary approval of the parties proposed settlement, which application was granted by the court on February 27, 2024.
- On May 22, 2024, the Court granted its final approval of the settlement, fully resolving the Securities Class Action.
- The settlement in the Securities Class Action will not resolve the Derivative Action.
- The Company is contesting the Derivative Action, but may pursue settlement negotiations, as it deems appropriate.
Related Party Transactions
- The Company is party to various lease agreements with 214 W Huron LLC, 220 W Huron Street Holdings LLC, 215 W Superior LLC and Wilson Tech 5, LLC, each of which is controlled by significant stockholders of the Company, to lease its former corporate offices in Chicago, Illinois and offices in Lindon, Utah.
- For the three and nine months ended September 30, 2024, the Company made aggregate lease payments of $1.3 million and $4.3 million, respectively.
- For the three and nine months ended September 30, 2023, the Company made aggregate lease payments of $1.5 million and $4.5 million, respectively.
- The lease agreement with 214 W Huron LLC expired during the nine months ended September 30, 2024.
Stakeholder Impact
- Shareholders may be concerned about the decrease in net revenues and adjusted EBITDA.
- Employees may be affected by the company's cost-saving initiatives, including reduced headcount.
- Customers may benefit from the company's focus on enhancing the consumer experience through its Encompass operating model.
- Health plan partners may benefit from the company's targeted marketing efforts and expanded agent base.
Next Steps
- The company will continue to refine its Encompass operating model through investments in technology.
- The company will continue to enhance its targeted marketing efforts to help health plan partners achieve targeted growth in specific markets and products.
- The company will analyze the implications of the CMS Final Rule with its health plan partners and closely monitor its effects on the Medicare landscape.
Key Dates
| Date | Description |
|---|---|
| 2019-09-13 | Date of the original Credit Agreement. |
| 2020-03-20 | Date of Amendment No. 1 to the Credit Agreement. |
| 2020-05-07 | Date of Incremental Facility Agreement and Technical Amendment No. 2 to the Credit Agreement. |
| 2020-06-11 | Date of Incremental Facility Agreement No. 3 to the Credit Agreement. |
| 2021-05-07 | Date of Amendment No. 4 to the Credit Agreement and Incremental Facility Agreement. |
| 2021-06-11 | Date of Amendment No. 5 to the Credit Agreement and Incremental Facility Agreement. |
| 2021-11-10 | Date of Amendment No. 6 to the Credit Agreement and Incremental Facility Agreement. |
| 2022-03-14 | Date of Amendment No. 7 to the Credit Agreement. |
| 2022-08-12 | Date of Amendment No. 8 to the Credit Agreement. |
| 2022-09-23 | Date of the Issuance of Series A Convertible Perpetual Preferred Stock. |
| 2022-11-09 | Date of Amendment No. 9 to the Credit Agreement. |
| 2023-03-15 | Date of Amendment No. 10 to the Credit Agreement. |
| 2024-03-12 | Date of Amendment No. 11 to the Credit Agreement. |
| 2024-08-30 | Date of the Purchase & Subscription Agreement with e-TeleQuote. |
| 2024-09-30 | Date of the acquisition of e-TeleQuote Insurance, Inc. |
| 2024-10-15 | Date of Amendment No. 12 to the Credit Agreement. |
| 2024-10-30 | Date of share information. |
| 2024-11-04 | Date of the Amendment and Restatement Agreement to the Credit Agreement. |
Keywords
GoHealth, e-TeleQuote, Medicare, insurance, acquisition, financial results, EBITDA, revenue, net income, operating expenses
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.